PI3Kδ Inhibition as a Potential Therapeutic Target in COVID-19

The spread of the novel human respiratory coronavirus (SARS-CoV-2) is a global public health emergency. There is no known successful treatment as of this time, and there is a need for medical options to mitigate this current epidemic. SARS-CoV-2 uses the angiotensin-converting enzyme 2 (ACE2) recept...

Descripción completa

Detalles Bibliográficos
Autores principales: Palma, Giuseppe, Pasqua, Teresa, Silvestri, Giovannino, Rocca, Carmine, Gualtieri, Paola, Barbieri, Antonio, De Bartolo, Anna, De Lorenzo, Antonino, Angelone, Tommaso, Avolio, Ennio, Botti, Gerardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472874/
https://www.ncbi.nlm.nih.gov/pubmed/32973818
http://dx.doi.org/10.3389/fimmu.2020.02094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472874/
https://www.ncbi.nlm.nih.gov/pubmed/32973818
http://dx.doi.org/10.3389/fimmu.2020.02094

Ejemplares similares